These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8297727)

  • 21. Direct interaction between verapamil and doxorubicin causes the lack of reversal effect of verapamil on P-glycoprotein mediated resistance to doxorubicin in vitro using L1210/VCR cells.
    Breier A; Drobná Z; Barancík M
    Neoplasma; 1998; 45(4):248-53. PubMed ID: 9890669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cellular pharmacology of detorubicin and doxorubicin in L1210 cells.
    Zenebergh A; Baurain R; Trouet A
    Eur J Cancer Clin Oncol; 1984 Jan; 20(1):115-21. PubMed ID: 6537910
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uptake, initial effects, and chemotherapeutic efficacy of harringtonine in murine leukemic cells sensitive and resistant to vincristine and other chemotherapeutic agents.
    Chou TC; Schmid FA; Feinberg A; Philips FS; Han J
    Cancer Res; 1983 Jul; 43(7):3074-9. PubMed ID: 6189591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Disruption of DNA synthesis and structure of mouse L1210 leukemia cells, sensitive and resistant to 1-methyl-1 nitrosourea and 1,3-bis(2-chloroethyl)-1-nitrosourea in vivo].
    Kukushkina GV; Peretolchina NM; Minenkova EA; Verovskiĭ VN; Sof'ina ZP
    Biokhimiia; 1984 Jul; 49(7):1189-98. PubMed ID: 6477985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activity of 3'-(3-cyano-4-morpholinyl)-3'-deaminoadriamycin in sensitive and resistant L5178Y lymphoblasts in vitro.
    Begleiter A; Leith MK; Johnston JB
    Cancer Res; 1994 Jan; 54(2):482-6. PubMed ID: 8275485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro antitumor activity of 3'-desamino-3'(2-methoxy-4-morpholinyl) doxorubicin on human melanoma cells sensitive or resistant to triazene compounds.
    Alvino E; Gilberti S; Cantagallo D; Massoud R; Gatteschi A; Tentori L; Bonmassar E; D'Atri S
    Cancer Chemother Pharmacol; 1997; 40(2):180-4. PubMed ID: 9182841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
    Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
    Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance.
    Roberts DW; Foglesong PD; Parganas E; Wiggins L
    Cancer Chemother Pharmacol; 1989; 23(3):161-8. PubMed ID: 2538249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study.
    Breier A; Drobná Z; Docolomansky P; Barancik M
    Neoplasma; 2000; 47(2):100-6. PubMed ID: 10985475
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of platinum uptake and glutathione levels in L1210 cells sensitive and resistant to cisplatin, tetraplatin or carboplatin.
    Nicolson MC; Orr RM; O'Neill CF; Harrap KR
    Neoplasma; 1992; 39(3):189-95. PubMed ID: 1528325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe depletion of cellular thiols and glutathione-related enzymes of a carmustine-resistant L1210 strain associates with collateral sensitivity to cyclophosphamide.
    Institoris E; Tretter L; Gaál D
    Cancer Chemother Pharmacol; 1993; 33(1):85-8. PubMed ID: 8269595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives.
    Ripamonti M; Capolongo L; Melegaro G; Gornati C; Bargiotti A; Caruso M; Grandi M; Suarato A
    Invest New Drugs; 1996; 14(2):139-46. PubMed ID: 8913834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Broad phase II and pharmacokinetic study of methoxy-morpholino doxorubicin (FCE 23762-MMRDX) in non-small-cell lung cancer, renal cancer and other solid tumour patients.
    Bakker M; Droz JP; Hanauske AR; Verweij J; van Oosterom AT; Groen HJ; Pacciarini MA; Domenigoni L; van Weissenbruch F; Pianezzola E; de Vries EG
    Br J Cancer; 1998; 77(1):139-46. PubMed ID: 9459159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.
    Di Blasi P; Bernareggi A; Beggiolin G; Piazzoni L; Menta E; Formento ML
    Anticancer Res; 1998; 18(4C):3113-7. PubMed ID: 9713519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-benzyladriamycin-14-valerate (AD 198)-resistant cells exhibit highly selective cross-resistance to other anthracyclines that circumvent multidrug resistance.
    Lothstein L; Hosey LM; Sweatman TW; Koseki Y; Dockter M; Priebe W
    Oncol Res; 1993; 5(6-7):229-34. PubMed ID: 7907237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of covalent DNA binding of morpholino and cyanomorpholino derivatives of doxorubicin.
    Lau DH; Durán GE; Sikic BI
    J Natl Cancer Inst; 1992 Oct; 84(20):1587-92. PubMed ID: 1404452
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selective DNA interaction of the novel distamycin derivative FCE 24517.
    Broggini M; Erba E; Ponti M; Ballinari D; Geroni C; Spreafico F; D'Incalci M
    Cancer Res; 1991 Jan; 51(1):199-204. PubMed ID: 1859575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
    Kido Y; Khokhar AR; al-Baker S; Siddik ZH
    Cancer Res; 1993 Oct; 53(19):4567-72. PubMed ID: 8402629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells.
    Hilton J
    Biochem Pharmacol; 1984 Jun; 33(12):1867-72. PubMed ID: 6732847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.